1.4M
Downloads
1072
Episodes
Dr Jack Cush reviews the news, journal reports and regulatory decisions from the past week on RheumNow.com
Episodes
Thursday Jun 19, 2025
Thursday Jun 19, 2025
Resilience or Resignation? Rethinking Pain, Aging, and Quality of Life
Spondyloarthritis Panel: Eular 2025
Thursday Jun 19, 2025
Thursday Jun 19, 2025
Leading rheumatology experts discuss the latest research, treatment advances, and clinical insights in axial spondyloarthritis. Hear what’s new from EULAR 2025 and what it means for improving patient outcomes.
Wednesday Jun 18, 2025
Wednesday Jun 18, 2025
Digital Behavioural Therapy for Persistent Pain in Axial Spondyloarthritis
There's an App for That (and it works): the AXIA RCT
Tuesday Jun 17, 2025
Tuesday Jun 17, 2025
Eular 2025 PsA Topic Panel
Assessment of Peripheral Arthritis in Spondyloarthritis
IL-17 inhibitors - Novel Drugs
IL17 inhibitors - Long-term Extensions and Uveitis
IL17 inhibitors - STAMP T2T and Combinations
Using AI for Reading PET/CT in Rheumatoid Arthritis
Tuesday Jun 17, 2025
Monday Jun 16, 2025
Monday Jun 16, 2025
Leading experts in rheumatology dive into the latest advances, treatment strategies, and emerging research in rheumatoid arthritis. Don’t miss this in-depth panel as they unpack key findings from EULAR 2025 and discuss what’s next for RA care.
Monday Jun 16, 2025
Monday Jun 16, 2025
Efficacy and Safety of Xeligekimab in AS
Sonelokimab in PsA
Seronegative Arthritis Breakthroughs
Novel Therapies in Axial Spondyloarthritis
Monday Jun 16, 2025
Monday Jun 16, 2025
JAK Inhibitors: The Latest from the JAK-pot Study
Does Abatacept Buy You Time Off RA?
How to Properly Use Steroids in Early RA: Oral vs Parenteral
All Rheumatoid Arthritis is Not the Same
Jekyll and Hyde: which RA-ILD is it?
RA treatment: A Constant State of Evolution
Monday Jun 16, 2025
Monday Jun 16, 2025
Who/When to Treat Clinically Suspect Arthralgia
Thoughtful, Effective RA Care Should be Guided by Need —Not Age
The Impact of Biologics on Methotrexate Adherence
Jokes Aside: The Impact of Laughter in RA
JAK Safety Update
Why is RA Difficult to Treat?
DMARD Combinations in RA Treatment
Increased Risk of VTE in RA: Lessons Learned from 40 Years of Data
ALTO: Long-term Outcomes of APIPPRA
Monday Jun 16, 2025
Monday Jun 16, 2025
Efficacy and Safety of Xeligekimab in AS
Lessons on Uveitis and AxSpA
Difficult to Treat Axial Spondyloarthritis
MRI Lesions in Early axSpA vs Non-axSpA
Emerging Therapies in Axial Spondyloarthritis
Chronic Pain in AxSpA Beyond Fibromyalgia
Novel Therapies in Axial Spondyloarthritis
GLP 1 Receptor Agonists in axSpA Patients